Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks

BACKGROUND: The aim of this multicenter, randomized, double-blind study was to examine the effect of lobeglitazone, a novel thiazolidinedione, on the changes in bone mineral density (BMD) in patients with type 2 diabetes mellitus. METHODS: A 24-week, double-blinded phase was followed by a 28-week, o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Metab J
Main Authors: Lim, Soo, Kim, Kyoung Min, Kim, Sin Gon, Kim, Doo Man, Woo, Jeong-Taek, Chung, Choon Hee, Ko, Kyung Soo, Park, Jeong Hyun, Park, Yongsoo, Kim, Sang Jin, Jang, Hak Chul, Choi, Dong Seop
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Diabetes Association 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5663677/
https://ncbi.nlm.nih.gov/pubmed/29086536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2017.41.5.377
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados